Medication (generic)
Metformin IR
Starting dose
500 mg once daily with food
Typical titration / target
Increase by 500 mg every 1-2 weeks to 1000 mg twice daily
Monitoring / notes
Hold during acute illness or dehydration.
Prescribing
Metformin start
Starting doses, titration steps, and renal considerations for metformin.
Last reviewed 2026-01-05|endocrine | diabetes | medication
Editorial feedback
Suggest an update
Flag outdated guidance or propose revised wording for this page. Do not include PHI or patient identifiers.
Jump to
Dosing quick reference
Medication (generic)
Metformin XR
Starting dose
500 mg once daily with evening meal
Typical titration / target
Increase by 500 mg every 1-2 weeks to 2000 mg once daily
Monitoring / notes
GI side effects improve with slow titration.
| Medication (generic) | Starting dose | Typical titration / target | Monitoring / notes |
|---|---|---|---|
| Metformin IR | 500 mg once daily with food | Increase by 500 mg every 1-2 weeks to 1000 mg twice daily | Hold during acute illness or dehydration. |
| Metformin XR | 500 mg once daily with evening meal | Increase by 500 mg every 1-2 weeks to 2000 mg once daily | GI side effects improve with slow titration. |
Contraindications
- Avoid initiation if eGFR is below 30 mL/min/1.73 m2.
- Avoid when metabolic acidosis is present or suspected.
- Hold during severe intercurrent illness with dehydration, hypoxia, or unstable hemodynamics.
Renal and hepatic considerations
- Reduce dose and monitor more often when eGFR is 30-44.
- Reassess renal function promptly after acute illness or nephrotoxic exposures.
- Use extra caution in significant hepatic impairment due to lactic acidosis risk context.
Pregnancy and lactation cautions
- Review pregnancy intent and use a pregnancy-specific diabetes plan when relevant.
- Discuss potential perinatal treatment alternatives and shared decision-making before conception.
- During lactation, confirm maternal-infant monitoring expectations in the ongoing care plan.
Monitoring checkpoints
- Check renal function at baseline and at clinically appropriate intervals.
- Check B12 periodically for long-term therapy.
- Review GI tolerance and adherence after each titration step.
Stop or escalate criteria
- Stop and escalate immediately if lactic acidosis is suspected.
- Hold and reassess during acute dehydration, sepsis concern, or significant renal decline.
- Escalate treatment strategy when glycemic targets are not reached despite optimized tolerated dosing.